CoinVoice latest news, Nasdaq-listed company Prenetics announced the transfer of its ownership in ACT Genomics Holdings Company Limited to Delta Electronics Co., Ltd. for $71.78 million, leaving the company with cash reserves of approximately $86 million, with expected cash and short-term assets totaling $117 million. The company maintains a zero-debt balance sheet, allowing it to explore other financial management options, including digital asset adoption and Bitcoin financial strategies. [Original link]